TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 390 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1116:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-087768 |
| 2026-08-1116:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-087756 |
| 2026-05-1216:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-055081 |
| 2026-05-1216:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-055070 |
| 2026-04-0121:53 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001213900-26-037918 |
| 2026-03-3017:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-036519 |
| 2026-03-3017:43 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-036515 |
| 2026-01-2117:43 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-005779 |
| 2025-12-1616:01 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-122240 |
| 2025-11-1320:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-109479 |
| 2025-11-1217:27 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109381 |
| 2025-11-0316:02 ET | DEF 14A | Proxy statementPeriod 2025-12-15 | 0001213900-25-105183 |
| 2025-08-1216:34 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075003 |
| 2025-08-1216:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-074975 |
| 2025-05-1316:37 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042697 |
| 2025-05-1316:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042663 |
| 2025-04-3017:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001213900-25-037713 |
| 2025-04-0906:30 ET | 8-K | 8.01 Other events | 0001213900-25-030089 |
| 2025-03-2716:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001013762-25-003442 |
| 2025-03-2716:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-25-003407 |
| 2024-12-0517:15 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-106095 |
| 2024-11-1216:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-096811 |
| 2024-11-1216:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-096804 |
| 2024-10-2517:00 ET | DEF 14A | Proxy statementPeriod 2024-12-05 | 0001213900-24-090849 |
| 2024-09-2017:00 ET | 8-K | 5.08 Item not in the standard list | 0001213900-24-080719 |
| 2024-08-1217:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-067771 |
| 2024-08-1216:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-067670 |
| 2024-05-1016:18 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-041738 |
| 2024-05-1016:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-041735 |
| 2024-04-2917:00 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001213900-24-037258 |
| 2024-03-2916:32 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028003 |
| 2024-03-2916:29 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-027998 |
| 2023-11-1709:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-119332 |
| 2023-11-1416:31 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001193125-23-277143 |
| 2023-11-1416:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-277136 |
| 2023-08-1817:18 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001193125-23-216056 |
| 2023-08-1407:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001193125-23-211458 |
| 2023-08-1407:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-211446 |
| 2023-07-1017:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-23-184765 |
| 2023-07-0616:38 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-182808 |
| 2023-06-3008:29 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-076713 |
| 2023-06-2807:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-176709 |
| 2023-05-1717:01 ET | DEF 14A | Proxy statementPeriod 2023-06-26 | 0001193125-23-147098 |
| 2023-05-1516:24 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001193125-23-145064 |
| 2023-05-1516:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-145019 |
| 2023-05-0517:26 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-23-137263 |
| 2023-05-0117:03 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001193125-23-130656 |
| 2023-04-2117:14 ET | 8-K | 8.01 Other events | 0001193125-23-110686 |
| 2023-04-0716:46 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001564590-23-005514 |
| 2023-04-0716:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-095317 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:52 ET. Listed shows no prices and gives no investment advice.